Sowilo India Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.15 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.88 M
- Revenue Growth 48.05%
- Profit Growth 138.69%
- Ebitda 44.67%
- Net Worth 87.99%
- Total Assets 42.38%
About Sowilo India Pharmaceuticals
Sowilo India Pharmaceuticals Private Limited (SIPPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 October 2018 (Six years and four months 6 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.15 M.
The company currently has active open charges totaling ₹3.88 M.
Savita Tiwari, Poonam Srivastava, Jatin Trivedi, and One other member serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909DL2018PTC340658
- Company No.
340658
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Oct 2018
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Sowilo India Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Savita Tiwari  | Director | 17-Oct-2018 | Current |
| Poonam Srivastava | Director | 17-Oct-2018 | Current |
| Jatin Trivedi | Director | 13-Aug-2019 | Current |
| Tripti Shukla | Director | 11-Jun-2021 | Current |
Financial Performance of Sowilo India Pharmaceuticals.
Sowilo India Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.05% increase. The company also saw a substantial improvement in profitability, with a 138.69% increase in profit. The company's net worth Soared by an impressive increase of 87.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sowilo India Pharmaceuticals?
In 2023, Sowilo India Pharmaceuticals had a public holding of 33.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.88 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.39 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jul 2023 | Hdfc Bank Limited | ₹2.50 M | Open |
| 30 Apr 2021 | Hdfc Bank Limited | ₹1.38 M | Open |
How Many Employees Work at Sowilo India Pharmaceuticals?
Sowilo India Pharmaceuticals has a workforce of 30 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sowilo India Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sowilo India Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.